EUVIMEDEUVIMED entdecken
Crossref

Maresin 1 ameliorates myocardial ischaemia‒reperfusion injury by promoting tissue resident macrophage efferocytosis

Xuan Sun iD, Yuting Feng, Yawei Zhao, Yue Cai, Zhenzhu Cao, Yu Zhang, Zhonghai Wei, Anning Du iD, Biao Xu iD

Cardiovascular Research · 26.03.2026 · 122 (3) · 397-411

DOI: 10.1093/cvr/cvag017 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, online erschienen am 20.01.2026. Verfasst von Xuan Sun und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing Key Laboratory for Cardiovascular Information an…. Hauptthemen laut MEDLINE: Docosahexaenoic Acids, Myocardial Reperfusion Injury, Efferocytosis, Macrophages. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Key Research and Development Plan, National Natural Science Foundation of China, Jiangsu Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Myocardial ischaemia‒reperfusion (I/R) injury triggers a robust inflammatory storm cascade that critically compromises reperfusion efficacy following acute myocardial infarction. Enhanced efferocytosis by cardiac resident macrophages (RMs) has therapeutic potential for inflammation resolution. The unsaturated long-chain fatty acid Maresin1 (MaR1) exhibits potent anti-inflammatory properties that is devoid of immunosuppressive effects. However, its therapeutic potential in myocardial I/R injury and regulatory mechanisms in cardiac RMs remains unexplored. Methods and results A clinical case‒control study was conducted and revealed a negative association between circulating MaR1 levels and inflammatory markers and the severity of I/R injury in patients with ST-elevation myocardial infarction. Mice treated with MaR1 after myocardial I/R injury showed improvements in cardiac function and efferocytosis by cardiac RMs. Genetic ablation of cardiac RMs abolished MaR1-mediated cardioprotection. To explore the mechanism underlying this protection, we performed transcriptomic, metabolomics, and lipidomic analyses and identified fatty acid β-oxidation potentiation as a key metabolic signature in MaR1-treated RMs. Moreover, MaR1 directly bound peroxisome proliferator-activated receptor γ (PPARγ), inducing the transcriptional activation of its downstream efferocytosis-related target CD204. Specific knockout of PPARγ in RMs significantly attenuated MaR1-enhanced efferocytosis. Notably, oral supplementation with the MaR1 precursor docosahexaenoic acid (DHA) recapitulated these cardioprotective effects.

Conclusion

Our findings prove that MaR1 plays a protective role in myocardial I/R injury by facilitating efferocytosis by RMs and the resolution of inflammation. These results offer novel therapeutic perspectives for the management of myocardial I/R injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Docosahexaenoic AcidsMyocardial Reperfusion InjuryEfferocytosisMacrophagesMyocardiumST Elevation Myocardial InfarctionAnti-Inflammatory AgentsPhagocytosisAnimalsSpecialized Pro-Resolving MediatorsHumansMaleDisease Models, AnimalMice, Inbred C57BLPPAR gammaSignal TransductionCase-Control StudiesMice, KnockoutInflammation MediatorsFemale

Stichwörter der Autor:innen

EfferocytosisInflammationMaresin 1Myocardial I/R injuryResident macrophage

Substanzen

Docosahexaenoic Acids7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acidPPAR gammaInflammation MediatorsAnti-Inflammatory AgentsPparg protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Nanjing Drum Tower Hospital, Medical School of Nanjing University, Nanjing Key Laboratory for Cardiovascular Information and Health Engineering Medicine, No. 321 Zhongshan Road, Nanjing 210008,…
  • Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111 XianXia Road, Shanghai 200336, China.
  • Department of Cardiology, Nanjing Drum Tower Hospital, Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine, 358 Zhongshan Road, Nanjing 210008, China.

ORCID-Profile: Xuan Sun, Anning Du, Biao Xu

Förderung

  • Key Research and Development Plan
  • National Natural Science Foundation of China
  • Jiangsu Natural Science Foundation
  • Science Technology Foundation

Zitieren

APA

Sun, X., Feng, Y., Zhao, Y., Cai, Y., Cao, Z., Zhang, Y., Wei, Z., Du, A., & Xu, B. (2026). Maresin 1 ameliorates myocardial ischaemia‒reperfusion injury by promoting tissue resident macrophage efferocytosis. Cardiovascular Research, 122(3), 397-411. https://doi.org/10.1093/cvr/cvag017

Vancouver

Sun X, Feng Y, Zhao Y, Cai Y, Cao Z, Zhang Y, et al. Maresin 1 ameliorates myocardial ischaemia‒reperfusion injury by promoting tissue resident macrophage efferocytosis. Cardiovascular Research. 2026;122(3):397-411. doi:10.1093/cvr/cvag017

BibTeX
@article{Sun2026,
  author = {Sun, Xuan and Feng, Yuting and Zhao, Yawei and Cai, Yue and Cao, Zhenzhu and Zhang, Yu and Wei, Zhonghai and Du, Anning and Xu, Biao},
  title = {Maresin 1 ameliorates myocardial ischaemia‒reperfusion injury by promoting tissue resident macrophage efferocytosis},
  journal = {Cardiovascular Research},
  year = {2026},
  volume = {122},
  number = {3},
  pages = {397--411},
  doi = {10.1093/cvr/cvag017}
}
Kostenlos starten →